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During mammalian hindbrain development, sensory axons grow along highly stereotyped routes within the cranial
mesenchyme to reach their appropriate entry points into the neuroepithelium. Thus, trigeminal ganglion axons always
project to rhombomere (r)2, whilst facial/acoustic ganglia axons always project to r4. Axons are never observed to enter the
mesenchyme adjacent to r3, raising the possibility that r3 mesenchyme contains an axon growth-inhibitory activity.
Conversely, in mice which lack the erbB4 receptor (normally expressed in r3), trigeminal and facial/acoustic ganglia axons
misproject into r3 mesenchyme, suggesting that the putative axon barrier is absent. To investigate this hypothesis, we have
developed an in vitro model in which dissociated wild-type embryonic trigeminal ganglion neurons are cultured on
ongitudinal cryosections of embryonic mouse head. We observed that on wild-type embryonic day 10 (E10) cryosections,
eurites generally failed to grow into r3 mesenchyme from the adjacent r2 or r4 mesenchyme. This barrier was removed if
ryosections were pretreated with chondroitinase or were washed with excess chondroitin 6-sulphate or hypertonic saline.
y contrast, when trigeminal neurons were seeded onto cryosections of E10 erbB4 2/2 embryo heads their neurites readily
ntered mutant r3 mesenchyme. Immunohistochemical analysis demonstrated chondroitin-sulphated proteoglycans
hroughout the cranial mesenchyme in both wild-type and erbB4 2/2 embryos. We propose that trigeminal axons are
xcluded from wild-type r3 mesenchyme by a growth-inhibitory activity which associates with chondroitin-sulphated
roteoglycans and that the synthesis of this activity may rely on signals transduced by erbB receptors. © 1999 Academic Press
Key Words: hindbrain; trigeminal ganglion; axon growth inhibition; proteoglycans; erbB4.
i
t
a
m
p
d
i
v
c
w
a
t
d
(
cINTRODUCTION
During development, growing axons are constrained to
appropriate pathways by combinations of growth-
promoting and growth-inhibitory cues within the surround-
ing tissues and also by neuronal changes in the responsive-
ness of growth cones to these various guidance cues (Keynes
et al., 1997; Walsh and Doherty, 1997; Chiba and Keshish-
ian, 1996; Culotti and Kolodkin, 1996; Nieto, 1996; Keynes
and Cook, 1995). In the developing vertebrate hindbrain, it
remains unclear which of these mechanisms predominate
in dictating how centrally projecting sensory axons from
individual ganglia navigate to their well-defined entry sitesl
t
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All rights of reproduction in any form reserved.nto the neuroepithelium. It has been suggested that the
ransient segmentation of the hindbrain neuroepithelium
long its anteroposterior axis into metameric compart-
ents called rhombomeres (r) regulates the segmented
attern of cranial sensory ganglia and their nerves (Lums-
en and Krumlauf, 1996). Because cranial ganglia form
mmediately adjacent to the rhombomere they will inner-
ate, one possibility is that short-range chemoattractive
ues are released by neural crest-derived boundary cap cells
hich populate the presumptive axon entry sites in r2, r4,
nd r6 (Niederlander and Lumsden, 1996). However, cocul-
ures of hindbrain and cranial ganglia have so far failed to
etect any chemoattractive activity for sensory axons
Tucker et al., 1996). Another possibility is that repulsive
ues exist within the mesenchyme or neuroepithelial basal
amina between neighbouring entry sites to constrain axons
o enter their appropriate rhombomere (Keynes et al., 1991).
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86 Golding et al.One such candidate repulsive activity are chondroitin-
sulphated proteoglycans (CSPGs), which have been found at
high concentrations in several areas of developing verte-
brates that act as barriers to axon growth and cell migration
(Silver, 1994; Oakley and Tosney, 1991; Snow et al., 1991).
Some CSPGs are known to directly inhibit growth
(Fernaud-Espinosa et al., 1998), whilst others act indirectly
y binding to, and thereby modulating the effects of, vari-
us cell adhesion molecules and growth factors (Grumet et
l., 1996; Margolis and Margolis, 1997). However, the
resence of CSPGs does not always correlate with the
estriction of axon growth, since some CSPGs are reported
o stimulate neurite growth (Faissner et al., 1994). Another
lass of sulphated proteoglycans, heparan sulphate proteo-
lycans (HSPGs), are found in association with basement
embranes in the developing vertebrate nervous system
Walz et al., 1997; Treloar et al., 1996) and various members
ither have a slight inhibitory effect (Tonge et al., 1997) or
stimulatory effect (Hantaz-Ambroise et al., 1987) on axon
rowth, most likely by sequestering or presenting various
rowth factors (Walz et al., 1997).
Further insight into the mechanisms which pattern cra-
ial axon projections can be gained from studies of mutant
ice, lacking certain segmentally expressed transcription
actors. Thus, in mice lacking Hoxa-2 (Gavalas et al., 1997),
oxb-1 (Studer et al., 1996), or Krox20 (Schneider-
aunoury et al., 1997), misrouting of cranial motor axons
s observed, apparently as a result of rhombomere deletions
nd/or respecification of rhombomere identity. Another
utant mouse, which lacks the erbB4 receptor tyrosine
inase (a receptor for neuregulin), shows axon pathfinding
efects in the hindbrain, although rhombomeric segmenta-
ion and identity appear to be unaffected (Gassmann et al.,
995). Furthermore, in erbB4 2/2 mutants it was observed
hat mistargeting of axons is not only confined to motor
eurons, but also affects the central projections of trigemi-
al and facial/acoustic sensory ganglia. Thus, trigeminal
anglion axons grow to their appropriate entry site in r2, but
lso grow inappropriately through r3 mesenchyme to the
ntry site in r4. Similarly, facial/acoustic ganglia axons
row to their appropriate entry site in r4 but also grow via
3 mesenchyme to the trigeminal entry site in r2 (Gass-
ann et al., 1995). This observation raises the possibility
hat wild-type r3 mesenchyme contains an axon growth-
nhibitory activity whose synthesis is regulated by erbB4
ignalling within r3 and is therefore absent in erbB4 2/2
mbryos. In this study we use a cryoculture technique to
emonstrate that wild-type (but not erbB4 2/2) r3 mesen-
hyme indeed contains a barrier to axon growth at an
ppropriate time during hindbrain development to influ-
nce the central projections of trigeminal and facial/
coustic sensory neurons. Furthermore, we provide evi-
ence that the r3 mesenchyme neurite growth inhibitor
ight be presented to the axons by chondroitin-sulphated
roteoglycans within the cranial mesenchyme.
Copyright © 1999 by Academic Press. All rightMATERIALS AND METHODS
Animals
A neo cassette was inserted into exon 2 of the mouse erbB4 gene
by homologous recombination, thereby rendering the gene product
nonfunctional (Gassmann et al., 1995). A breeding colony of
heterozygous erbB4 1/2 mice was maintained at NIMR and the
erbB4 2/2 genotype of embryos was confirmed by PCR analysis of
yolk-sac DNA using erbB4-specific primers (Gassmann et al.,
1995). Wild-type CBA mice were obtained from a breeding colony
at NIMR.
Cryoculture
Wild-type E8–E10 or erbB4 2/2 E10 embryos were bisected
along a line parallel with the dorsal surface of the hindbrain, from
the thorax to the forebrain (Fig. 1A). The dorsal half of each embryo
was mounted on card, dorsal surface uppermost, in a thin smear of
cryoembedding compound (Bright) and was snap frozen in liquid
nitrogen. Longitudinal 10-mm cryosections were collected on ster-
ile polylysine-coated glass coverslips (13 mm diameter; Chance
Propper) and stored at 270°C for up to 2 weeks (Fig. 1A).
Trigeminal ganglia or the ventral third of r2 plus r3 neuroepi-
thelium (containing trigeminal motor neurons and interneurons) or
telencephala were dissected from E10 wild-type embryos in
DMEM, digested with 500 ml 11 U/ml trypsin (Worthington) for 10
in at 37°C, washed in three changes of DMEM, and triturated in
0 ml of 0.25 mg/ml soybean trypsin inhibitor type II (Sigma) plus
0.05 mg/ml DNase type I (Sigma) in Hanks’ balanced salts (Gibco).
Dissociated cells were diluted to 20,000 cells/ml in F14 medium
(Davies, 1996) containing 10 ng/ml NT-3 and 10 ng/ml BDNF
(R&D Systems). Coverslips bearing head cryosections were placed
individually into four-well culture dishes (Nunc) and 500 ml of cell
suspension was added to each well (Fig. 1A). Cultures were main-
tained in a humidified atmosphere of 5% CO2 and 95% air at 37°C
for 18 h and then fixed with 2% paraformaldehyde for 15 min and
permeabilized with methanol for 3 min. Cryocultures were dual
immunostained with rabbit anti-laminin (1:200; Sigma), to allow
identification of the rhombomeres, and mouse monoclonal anti-
b3-tubulin (TUJ1, 1:1000; BAbCO, Richmond), to identify applied
neurons and their neurites. Primary antibodies were visualised
with Cy2-conjugated anti-rabbit Ig and Cy3-conjugated anti-mouse
Ig secondary antibodies (both 1:200; Amersham) and counter-
stained with DAPI nuclear stain (5 mg/ml, Sigma). Cryocultures
were mounted on glass slides in Glycergel (DAKO) and photo-
graphed using an epifluorescence microscope (Zeiss).
Modifications of Cryoculture Conditions
In some experiments, cryosections were pretreated with various
solutions and then extensively washed with PBS before applying
dissociated trigeminal ganglion neurons and culturing overnight.
These pretreatments included 100 ml chondroitin sulphate-A
CS-A, 25 mg/ml in PBS, Sigma) for 2 h at 37°C; 100 ml chondroitin
ulphate-C (CS-C, 25 mg/ml in PBS, Sigma) for 2 h at 37°C; 100 ml
heparin (grade 1-A sodium salt, 25 mg/ml in PBS, Sigma) for 2 h at
37°C; 100 ml 0.5 M NaCl (in phosphate buffer, pH 7.2) for 2 h at
7°C; 30 ml chondroitinase ABC (CH-ase, EC 4.2.2.4, 6 U/ml in 50
M Tris–HCl, pH 8.0, containing 400 mg/ml BSA, Oxford Glyco-Sciences) for 5 h at 37°C; 30 ml of CH-ase buffer only for 5 h at 37°C
as a control; 30 ml hyaluronidase (EC 3.2.1.35, 5 U/ml in 0.1 M
s of reproduction in any form reserved.
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87Axon Guidance in Embryonic Cranial Mesenchymesodium acetate buffer, pH 5, ICN) for 4 h at 37°C; 30 ml heparitinase
(EC 4.2.2.8, 0.5 U/ml in 2.5 mM calcium acetate, pH 7, ICN) for 4 h
at 37°C; 60 ml phosphatidylinositol phospholipase C (Pi-PLC, EC
.1.4.10, 10 U/ml in PBS, Oxford GlycoSciences) for 3 h at 37°C; or
00 ml PBS for 2 h at 37°C as a control. In some experiments the
ulture medium was supplemented with a mouse monoclonal
ntibody to the extracellular domain of erbB4 (clone H4.72.8, 1:40,
mg/ml, Neomarkers), previously shown to block the binding of
neuregulin to erbB4 (Chen et al., 1996), or a 1:40 dilution of normal
mouse serum as a control. After culturing with dissociated neu-
rons, all cultures were fixed and dual immunostained with anti-
laminin and anti-b3-tubulin antibodies, as described.
Statistical Analysis of Neurite Interactions
with Cryosections
In immunostained cryocultures, mesenchyme adjacent to the
rhombomeres was divided into segments by extending an imagi-
nary line out from each rhombomere boundary, perpendicular to
the neuraxis. Neurites which encountered the boundaries between
r2, r3, or r4 mesenchymal segments were quantified as follows: The
number of neurites which extended by more than 20 mm onto r3
mesenchyme from r2 or r4 mesenchyme was expressed as a
percentage of the total number of neurites within r2 or r4 mesen-
chyme which encountered the r3 mesenchyme boundary. Con-
versely, the number of neurites which extended onto r2 or r4
mesenchyme from r3 mesenchyme was expressed at a percentage
of the total number of neurites within r3 mesenchyme which
encountered the boundary with r2 or r4 mesenchyme. Each experi-
mental condition was repeated on three to nine independent
occasions to produce a mean value for the percentage of neurites
entering or leaving r3 mesenchyme. A two-tailed Student’s t test
as used to determine the significance of any differences between
he mean percentages derived from each experimental condition.
hen multiple comparisons were made to a single control value,
he t test was subject to sequential Bonferroni corrections.
Creation of Artificial Substrate Boundaries
in Vitro
A mixture of Protein A (5 mg/ml, Sigma) and fluoresceinated
latex beads (1:500, 50 nm diameter, Polysciences) in PBS was
dispensed as discrete 5-ml spots onto polylysine-coated glass cov-
rslips, incubated for 2 h at 25°C and then washed in 3 3 1-ml
hanges of PBS. Nonspecific binding was blocked by adding 500 ml
of DMEM containing 10% FCS (DMEM/F10) for 1 h. This was then
replaced for 2 h with 400 ml of DMEM/F10 containing 2 mg/ml of a
usion protein comprising the human immunoglobulin Fc domain
nd the extracellular domain of mouse erbB4 (a gift of Yosef
arden, Weizmann Institute, Rehovot, Israel). Control coverslips
ere instead incubated with 2 mg/ml of human IgG (Sigma). All
overslips were washed with three changes of DMEM, seeded with
00 ml of trigeminal ganglia cell suspension, and cultured over-
ight. We confirmed that protein A-treated areas of coverslips
ound erbB4-Fc and human IgG by immunostaining with an
RP-conjugated anti-human Ig F(ab9)2 fragment antibody (1:500,
Amersham). The proportion of neurites which grew into the
erbB4-Fc or control IgG-coated areas was counted on an epifluores-
cence microscope, equipped with phase contrast optics.
a
Copyright © 1999 by Academic Press. All rightImmunohistochemistry
Some cryosections were fixed with 4% paraformaldehyde and
then washed with PBS, blocked with 10% skimmed milk powder in
PBS for 1 h, and immunostained with either a mouse monoclonal
anti-chondroitin sulphate proteoglycan antibody (clone CS-56,
1:200; Sigma) or a rat monoclonal anti-heparan sulphate proteogly-
can (perlecan core protein) antibody (clone A7L6, 1:300; Chemi-
con), followed by either Cy3-conjugated anti-mouse Ig secondary
antibody (1:200; Amersham) or Cy-2-conjugated anti-rat Ig second-
ary antibody (1:200; Amersham), respectively, and 5 mg/ml DAPI
nuclear stain (Sigma). Other cryosections were immunostained
with a mouse monoclonal anti-chondroitin-6-sulphate proteogly-
can (C6SPG) antibody (1:500; ICN), which specifically recognises
the attachment site of C6S to the core protein and therefore
requires this epitope to be unmasked by predigesting unfixed
cryosections with 6 U/ml CH-ase for 4 h at 37°C. Treated cryosec-
tions were then washed and fixed with 4% paraformaldehyde
before being blocked and incubated with anti-C6SPG. Control
sections, which were not predigested with CH-ase, did not demon-
strate any immunoreactivity with anti-C6SPG.
In Situ Hybridisation
A plasmid, containing a 600-bp amino-terminal-encoding erbB4
cDNA (Gassmann et al., 1995), was used for the preparation of
antisense digoxigenin-labelled riboprobe. Whole mount in situ
hybridisation was performed on E9–E10 wild-type and erbB4 2/2
embryos, using 400 ng/ml riboprobe, according to the method of
Wilkinson and Nieto (1993). Transverse vibratome sections were
cut through some embryos after staining.
RESULTS
Trigeminal Neurites Avoid Entering Wild-Type
r3 Mesenchyme
Dissociated wild-type E10 trigeminal ganglion neurons
were cultured overnight on longitudinal cryosections of
wild-type E8–E10 head, which were subsequently immuno-
stained with anti-laminin and anti-b3-tubulin antibodies.
On all ages of hindbrain substrate, neurons attached ran-
domly and extended bipolar neurites. Outside the neuroepi-
thelium, neurites were seen to grow both within the mes-
enchyme and along the pial basal lamina (Figs. 1B–1D).
Initially, we examined how neurites growing alongside the
neuroepithelium on E10 cryosections behaved at the
boundaries between r2 and r3 mesenchyme and between r3
and r4 mesenchyme. Neurites seldom grew onto r3 mesen-
chyme from r2 mesenchyme or r4 mesenchyme (32.4 6
.7%, 129 neurites, n 5 9), although neurites readily grew
n the opposite direction, from r3 mesenchyme onto r2/r4
esenchyme (75.2 6 5.3%, 114 neurites, n 5 9; P , 0.0001)
Fig. 1D). Neurites which failed to grow onto r3 mesen-
hyme generally remained at the mesenchymal boundary,
s if paralysed, although their growth cones were rarely
ollapsed. However, a small population of neurites were
bserved to have turned around and continued growing
way from r3 mesenchyme (15 of 84 neurites examined).
To define the onset of the neurite growth-inhibitory
s of reproduction in any form reserved.
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Copyright © 1999 by Academic Press. All rightactivity within r3 mesenchyme, we seeded E10 neurons
onto E9 and E8 head cryosections and found that the barrier
to neurite growth onto r3 mesenchyme became progres-
sively weaker on younger cryosections. On E9 cryosections
54.2 6 8.0% of neurites (75 neurites, n 5 4) grew from r2 or
4 mesenchyme onto r3 mesenchyme (Fig.1C); whilst on E8
ryosections 71.4 6 2.8% of neurites (37 neurites, n 5 3)
rew onto r3 mesenchyme (Fig. 1B). The proportion of
eurites which grew in the opposite direction, from r3
esenchyme onto r2/r4 mesenchyme, also increased as the
ge of the hindbrain substrate was decreased, being 76.3 6
.1% (70 neurites, n 5 4) on E9 cryosections and 92.6 6
.4% (19 neurites, n 5 3) on E8 cryosections. However, the
ean length of neurite growth on the cryosections was not
ignificantly influenced by the age of the substrate, being
7.3 6 2.6 mm on E8 cryosections, 61.2 6 3.9 mm on E9
cryosections, and 51.3 6 4.2 mm on E10 cryosections (100
neurites measured in each case).
To determine whether neurites from other classes of
neuron were similarly sensitive to the r3 mesenchyme
growth-inhibitory activity, we seeded wild-type E10 head
cryosections with dissociated E10 neurons, isolated either
from the basal plate of r2/r3 hindbrain neuroepithelium
(mostly motorneurons, whose peripheral processes would
normally encounter r3 mesenchyme) or telencephalic neu-
rons (whose axons would normally not encounter any
mesenchyme adjacent to the hindbrain). Hindbrain neurons
were found to be sensitive to the growth-inhibitory activity
of r3 mesenchyme, with only 35.7 6 10.7% of their neurites
entering r3 mesenchyme from r2 or r4 mesenchyme (15
neurites, n 5 3), whilst these neurites readily grew out of r3
mesenchyme onto the adjacent r2/r4 mesenchyme (82.2 6
4.9%, 21 neurites, n 5 3; P , 0.02) (Fig. 2A). By contrast,
telencephalic neurons were unaffected by r3 mesenchyme,
with 67.2 6 16.8% of neurites growing into r3 mesenchyme
from r2 or r4 mesenchyme (18 neurites, n 5 3) and 56.5 6
10.8% of neurites growing out of r3 mesenchyme onto the
adjacent r2/r4 mesenchyme (19 neurites, n 5 3) (Fig. 2B).
FIG. 1. Mesenchyme adjacent to r3 becomes nonpermissive to
sensory axon growth between E8 and E10 in wild-type mouse
embryos. (A) Longitudinal cryostat sections of E8–E10 embryo
head were collected on polylysine-coated glass coverslips and used
as a substrate for the growth of E10 dissociated trigeminal ganglion
neurons. (B–D) Cultures were maintained overnight and then fixed
and immunostained with anti-laminin antibody (shown in green)
and anti-b3-tubulin antibody (orange), to reveal hindbrain struc-
tures and applied neurons (n), respectively. From E8 (B), E9 (C), to
E10 (D) the proportion of E10 neurites which extended from r2
mesenchyme or r4 mesenchyme onto r3 mesenchyme (boundary
marked by dashed line) declined progressively. NE, neuroepithe-
lium; MES, mesenchyme; GC, glass coverslip; OV, otic vesicle.
Arrows mark the line of the laminin-rich neuroepithelial basal
lamina. Bar, 50 mm.
s of reproduction in any form reserved.
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89Axon Guidance in Embryonic Cranial MesenchymeSome Pretreatments of Cryosections Disrupt the r3
Mesenchyme Growth-Inhibitory Activity
Pretreatment of wild-type E10 head cryosections with
either CH-ase, CS-C (composed chiefly of chondroitin
6-sulphate chains), or hypertonic saline all significantly
reduced the axon growth inhibitory activity of r3 mesen-
chyme (Fig. 3), compared with PBS-treated or CH-ase buffer-
only-treated (not shown) control cryosections. The CH-ase
data suggest that the inhibitory activity could be due to
either a CSPG or a CSPG-binding molecule. However, the
latter suggestion is favoured by the observation that the
activity can be eluted from cryosections by washing with
CS-C or hypertonic saline.
FIG. 2. Hindbrain motorneurons, but not telencephalic neurons
re sensitive to the r3 mesenchyme growth inhibitor. E10 wild-type
ead cryosections (stained green by anti-laminin antibody) were
eeded with dissociated neurons (n), derived from either E10 r2 plus
3 ventral neuroepithelium (A) or E10 telencephalon (B). Neurons
nd growing neurites are stained orange with anti-b3-tubulin
antibody. In A hindbrain motorneurons avoid growing neurites into
r3 mesenchyme from the adjacent r4 mesenchyme (arrow), whilst
in B telencephalic neurons are able to grow neurites into r3
mesenchyme (arrow). The boundary between r3 and r4 mesen-
chyme is marked with a dashed line. OV, otic vesicle. Bar, 50 mm.By contrast, pretreatment of E10 wild-type cryosections
with Pi-PLC, heparin, heparitinase, or CS-A (composed
Copyright © 1999 by Academic Press. All righthiefly of chondroitin 4-sulphate chains) had no significant
ffect on the proportion of neurites which grew onto r3
esenchyme (Fig. 3), suggesting that the activity is not
PI-linked to cell membranes, is unlikely to be a HSPG or
SPG-binding molecule, and may preferentially bind to
6SPG, rather than chondroitin-4-sulphated ones. In com-
arison to untreated cryosections, we found that all of the
retreatments appeared to reduce the potency of the r3
esenchyme barrier to some extent, suggesting that al-
hough the activity may associate with certain sulphated
roteoglycans, it is not firmly anchored to the mesenchyme
Fig. 3). Importantly, none of the pretreatments had any
ignificant effect on the proportion of neurites which grew
ut from r3 mesenchyme onto the adjacent r2/r4 mesen-
hyme, indicating that the pretreatments were not unspe-
ifically modifying the hindbrain substrate.
Following CS-A, CS-C, or PBS pretreatment, some cryo-
ections were immunostained with a chondroitin sulphate-
pecific antibody (CS-56). All three treatments yielded
dentical patterns of immunostaining (not shown, but re-
embling the immunostaining shown in Fig. 5C), indicating
hat applied soluble CS did not bind to cryosections and
hereby create an artificially uniform CS “carpet.” We
onfirmed that heparitinase was digesting HSPGs within
he cryosections and releasing UV-absorbing uronic acid
esidues by measuring the UV-absorbance of the enzyme
olution at 232 nm before and after digestion. The efficacy
f CH-ase digestion was confirmed by immunostaining
H-ase-treated cryosections with CS-56 antibody. CH-ase
reatment markedly reduced CSPG immunoreactivity
ithin the cryosections by 65–75% (quantified from CCD
amera-digitised epifluorescence images).
In addition to digesting CSPG, CH-ase is also known to
igest the glycosaminoglycan hyaluron (Yamagata et al.,
968). Therefore, to exclude the possibility that the ob-
erved effects of CH-ase treatment were due to hyaluron
egradation, some cryosections were pretreated with the
yaluron-specific degrading enzyme hyaluronidase. This
retreatment caused no significant increase in the propor-
ion of neurites which grew onto r3 mesenchyme (33.0 6
.2%, 27 neurites, n 5 3).
Neurites Readily Enter r3 Mesenchyme
in erbB4 2/2 Embryos
A previous study (Gassmann et al., 1995) has shown that
in mice which lack functional erbB4 receptor, centrally
projecting trigeminal and facial/acoustic ganglia axons
grow inappropriately into r3 mesenchyme. In this study, to
determine whether r3 mesenchyme of erbB4 2/2 mice
lacks an axon growth-inhibitory activity, we cultured E10
wild-type trigeminal neurons on cryosections of E10 erbB4
2/2 head. In contrast to the failure of neurites to grow onto
wild-type r3 mesenchyme, we found that on erbB4 2/2
cryosections neurons readily extended neurites from r2/r4
mesenchyme onto r3 mesenchyme (Fig. 4). Unlike wild-
type cryosections, the proportion of neurites which grew
s of reproduction in any form reserved.
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90 Golding et al.FIG. 3. Certain pretreatments of wild-type E10 cryosections remove the r3 mesenchyme neurite growth inhibitor. (A) Pretreating
ryosections with chondroitinase (CH-ase), chondroitin sulphate-C (CS-C), or 0.5 M NaCl increased the proportion of neurites which
xtended onto r3 mesenchyme from r2 mesenchyme or r4 mesenchyme, compared with PBS-treated controls (black bars). However,
retreatment with phospholipase-C (Pi-PLC), heparin, heparitinase (HEP-ase), or chondroitin sulphate-A (CS-A) had no significant effect on
he proportion of neurites which extended onto r3 mesenchyme. The r3 mesenchyme barrier was at its most potent on untreated
ryosections which had not been pretreated with any solution. The proportion of neurites which grew from r3 mesenchyme onto the
Copyright © 1999 by Academic Press. All rights of reproduction in any form reserved.
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91Axon Guidance in Embryonic Cranial Mesenchymeonto erbB4 2/2 r3 mesenchyme did not appear to be
ncreased by pretreating these cryosections with CS-C
Fig. 4B).
Comparison of Proteoglycan Immunoreactivity
in Wild-Type and erbB4 2/2 Embryos
Because the wild-type r3 mesenchyme inhibitory activity
appeared to associate with CSPG, we investigated the
developmental expression of CSPG and C6SPG in E9–E10
wild-type and erbB4 2/2 embryo hindbrains. In E9 wild-
ype embryos, CSPG immunoreactivity was present at
hombomere boundaries and was prominent within the
euroepithelial basal lamina and otic vesicle basal lamina
nd throughout the mesenchyme (Fig. 5A). By E10, CSPG
mmunoreactivity was reduced at rhombomere boundaries
nd within r2 mesenchyme and r4 mesenchyme at the sites
f condensing sensory ganglia (as has been reported in the
eveloping rat hindbrain by Morriss-Kay and Tuckett,
989), although immunoreactivity remained prominent in
he intervening mesenchyme adjacent to r3 (Figs. 5C and
D). In E9 erbB4 2/2 embryos, CSPG immunoreactivity
ppeared identical to that in wild-type embryos (Fig. 5B).
nti-C6SPG immunostained the same regions as anti-
SPG and no differences were detected between the stain-
ng patterns in wild-type or erbB4 2/2 embryos (data not
hown). In head cryosections of wild-type E10 embryos,
SPG immunoreactivity was present at rhombomere
oundaries and within the neuroepithelial basal lamina,
tic vesicle basal lamina, and blood vessels (Fig. 5E). We
etected no differences in the intensity or distribution of
SPG immunoreactivity between head cryosections of ei-
her wild-type (Fig. 5E) or erbB4 2/2 (Fig. 5F) embryos.
SPG immunoreactivity closely resembled laminin immu-
oreactivity (compare with Figs. 1–4) and, unlike CSPG
mmunoreactivity, we detected relatively little HSPG im-
unoreactivity within the cranial mesenchyme in either
ild-type or erbB4 2/2 embryos (compare Figs. 5E and 5F
ith Fig. 5C).
Spatiotemporal Expression of erbB4 mRNA
in Wild-Type Hindbrain
To further investigate the link between erbB4 expression
and the onset of the r3 mesenchyme barrier, we performed
erbB4 in situ hybridisation on E9 and E10 wild-type em-
bryos. At E9, erbB4 mRNA was present throughout the
rostrocaudal extent of r3 and r5 neuroepithelium, although
adjacent r2/r4 mesenchyme (clear bars) was not significantly altere
and then seeded with E10 trigeminal ganglion neurons (n), cultured
anti-b3-tubulin antibody (orange). In contrast to untreated cryosect
mesenchyme (bounded by dashed lines). Error bars in A are 6 SEM;
with Bonferroni correction. All experimental conditions were repeated
(eight times), heparin (four times), and untreated (nine times). Bar in B,
Copyright © 1999 by Academic Press. All rightt was most prominent dorsally and at the rhombomere
oundaries (Fig. 6A). In transverse sections through r3 and
5, near their boundaries with r4, erbB4 expression was
bserved within the proliferative ventricular zone (Figs. 6B
nd 6C) and throughout the thickness of the dorsal third of
he neuroepithelium in r5 (Fig. 6C), whilst in the dorsal
hird of r3 it was displaced marginally to the rhombic lip
nd the pial surface (Fig. 6B). Further rostrally, erbB4
RNA was detected in a continuum from r1 to the fore-
rain (Fig. 6A).
By E10, erbB4 mRNA became further focussed to the
hombomere boundaries in r3 and r5, whilst the expression
rom r1 into the forebrain remained continuous (Fig. 6D). In
ransverse sections through r1, r3, and r5 (Figs. 6E–6G,
espectively) erbB4 expression was now undetectable in the
entricular zone and was instead concentrated at the pial
urface and possibly within the pia itself, predominantly
ust ventral to the adjacent nerve entry points in r2 and r4.
trong erbB4 expression was also observed in the roof plate
f r1, r3, and r5 (Fig. 6E–6G). Thus, erbB4 expression in r3
and r5) shifts towards (but not into) the mesenchyme and
oncentrates at the rhombomere boundaries during the
ame period as the r3 mesenchyme axon barrier increases in
otency.
ErbB4 Does Not Directly Inhibit Neurite Growth
In our cryoculture experiments, neurites growing within
the mesenchyme were sometimes observed to grow along
the pial basal lamina. Although we were able to show that
in E10 wild-type embryos erbB4 was not expressed within
r3 mesenchyme (Fig. 6), we could not exclude the possibil-
ity that erbB4 was expressed by some r3 pial cells (Figs.
6E–6G). Thus, it remained possible that erbB4 might be
directly responsible for inhibiting the growth of some
neurites into r3 mesenchyme territory. To test this hypoth-
esis, two control experiments were performed. In the first,
cryocultures of E10 wild-type head cryosections were main-
tained in the presence of an antibody which masks the
extracellular domain of erbB4 (Chen et al., 1996). The
proportion of neurites which grew from r2/r4 mesenchyme
onto r3 mesenchyme under these conditions (35.9 6 5.6%,
8 neurites, n 5 3) did not differ significantly from un-
treated cryocultures or from control cryocultures in which
normal mouse serum was used instead of anti-erbB4 (34.3 6
6.7%, 23 neurites, n 5 4). In the second experiment, an
erbB4-Fc fusion protein was laid down in a pattern on glass
coverslips which were then used as a growth substrate for
ny of the pretreatments. (B) E10 cryosection pretreated with CS-C
night, and immunostained with anti-laminin antibody (green) and
(compare with Fig. 1D), neurites readily grow onto CS-C-treated r3
0.05 and **P , 0.01 significant difference from PBS control value,d by a
over
ions
*P ,in triplicate, except for PBS (four times), CS-A (four times), CS-C
50 mm.
s of reproduction in any form reserved.
n92 Golding et al.FIG. 4. Mesenchyme adjacent to r3 is not a barrier to sensory neurite growth in erbB4 2/2 embryos. (A) Wild-type E10 trigeminal ganglion
eurons (n) (stained orange with anti-b3-tubulin antibody) growing neurites on an E10 erbB4 2/2 head cryosection (stained green with
anti-laminin antibody). A neurite can be seen to grow from r4 mesenchyme onto r3 mesenchyme (boundary between r3 and r4 marked with
Copyright © 1999 by Academic Press. All rights of reproduction in any form reserved.
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93Axon Guidance in Embryonic Cranial Mesenchymedissociated trigeminal neurons. The proportion of neurites
which grew into the erbB4-containing regions (50.2 6 2.6%,
247 neurites, n 5 3) was no different from the proportion of
neurites which grew into similar regions, containing hu-
man IgG as a control (53.4 6 6.7%, 62 neurites, n 5 3). Both
of these data indicate that erbB4 does not directly inhibit
trigeminal neurite growth.
DISCUSSION
It is now widely accepted that axons navigate to their
appropriate targets in development by responding to
growth-attractive/promoting and growth-repulsive/inhib-
itory molecules. However, in most instances the relative
contributions of these cues remain unknown. In this study
we demonstrate that centrally projecting trigeminal sen-
sory axons (and trigeminal motor axons) might be con-
strained to their appropriate pathway within r2 mesen-
chyme by a CSPG-binding axon growth-inhibitory activity
within the neighbouring r3 mesenchyme. Moreover, the
production of this inhibitory activity may require signalling
events transduced via the neuregulin receptor erbB4, con-
centrated towards the pial surface and rhombomere bound-
aries within r3.
The presence of an axon growth-inhibitory activity in r3
mesenchyme is consistent with an earlier study which
proposed that r3 mesenchyme and r5 mesenchyme consti-
tute axon growth “exclusion zones” (Keynes et al., 1991). In
those experiments, when the neuroepithelium was dis-
placed caudally, such that axon entry/exit points in r2 and
r4 abutted r3 mesenchyme and r5 mesenchyme, respec-
tively, motor axons seldom grew out into the mesenchyme.
In agreement with this observation, we similarly found that
neurons isolated from r2 and r3 neuroepithelium seldom
grew into r3 mesenchyme, although neurites of telence-
phalic neurons exhibited no such preferential growth.
Therefore, although the cranial mesenchyme is not seg-
mented anatomically, it may be segmented molecularly
into growth-permissive and growth-inhibitory regions, to
which only specific classes of sensory and motor axons are
responsive, and this segmentation may be specified by
signals derived from the adjacent segmented neuroepithe-
lium.
Cranial sensory ganglia begin to form from E8.5 in the
mouse and centrally projecting sensory axons grow from
these ganglia towards the hindbrain neuroepithelium from
E9.5 (Davies and Lumsden, 1984; Stainier and Gilbert,
dashed line). (B) Quantification of the growth of wild-type neurites
wild-type or erbB4 2/2 cryosections (black bars) indicates tha
mesenchyme. Unlike wild-type cryosections, pretreatment of erbB
further increase the proportion of neurites which grow into r3 mes
difference from wild-type value, with Bonferroni correction. Wild-type
2/2 and erbB4 2/2 CS-C experiments were repeated five and three tim
Copyright © 1999 by Academic Press. All right990). The timing of this initial axon growth correlates
ith the appearance of the axon growth-inhibitory activity
n r3 mesenchyme around E9, suggesting that it may have a
ole in constraining the growth of the earliest centrally
rojecting trigeminal axons. Between E9 and E10, when the
ajority of centrally projecting axons are growing, the
nhibitory activity increases in potency and this coincides
ith a shift in the distribution of erbB4-expressing cells
owards the pial surface of the r3 neuroepithelium and thus
loser to the overlying r3 mesenchyme. The axon-
athfinding defects seen in erbB4 2/2 embryos are unlikely
o be related to any loss of this erbB4-expressing cell
opulation, since the truncated erbB4 mRNA transcripts
roduced by erbB4 2/2 embryos (which encode a biologi-
ally inactive form of erbB4) can be detected by in situ
ybridisation and show an identical distribution to the
ull-length erbB4 transcripts in wild-type embryos (data not
hown). Furthermore, our experiments with an erbB4-Fc
usion protein and a function-blocking antibody to the
xtracellular domain of erbB4, together with the observa-
ion that erbB4 mRNA is not expressed within r3 mesen-
hyme, suggest that erbB4 itself is not the axon growth-
nhibitory activity. Indeed, a previous study found that the
rbB4–Fc fusion protein actually potentiated neurite out-
rowth (Pinkas-Kramarski et al., 1997).
Although erbB4 does not directly inhibit axon growth, it
emains possible that signalling events mediated by erbB4
enerate the r3 mesenchyme-inhibitory activity. Consis-
ent with this scheme, between E8 and E10 r2, r4, and r6
euroepithelium express an erbB4 ligand, the transmem-
rane type I isoform of neuregulin (Meyer et al., 1997).
Thus, sites of neuregulin expression directly abut sites of
receptor expression in neighbouring rhombomeres. Neu-
regulin is also expressed throughout the hindbrain in a thin
layer of cells lying at, or just outside, the pial surface of the
neuroepithelium (Meyer and Birchmeier, 1994). These mar-
ginal cells lie close to, and may even be identical to, the
erbB4-expressing cells we find at the pial surface of the
neuroepithelium. We therefore propose that erbB4-
mediated signalling in cells at the margins of r3 induces
these cells either to secrete an axon growth-inhibitory
activity or to secrete a signalling molecule which induces
the neighbouring r3 mesenchyme to produce an axon
growth-inhibitory activity. Furthermore, our ability to dis-
place an inhibitory activity from wild-type cryosections
with CH-ase and CS-C, but not CS-A, suggests that it is not
a CSPG, but more likely binds to CSPGs and especially
C6SPGs. However, our initial attempts to extract this
r2 mesenchyme or r4 mesenchyme onto r3 mesenchyme in either
ignificantly higher proportion of neurites enter erbB4 2/2 r3
/2 head cryosections with chondroitin sulphate-C (CS-C) fails to
yme. Error bars are 6 SEM; *P , 0.05 and **P , 0.01 significantfrom
t a s
4 2
enchdata are the mean of nine independent experiments, whilst erbB4
es, respectively. OV, otic vesicle. Bar in A, 50 mm.
s of reproduction in any form reserved.
a94 Golding et al.FIG. 5. Distribution of chondroitin-sulphated proteoglycans (CSPG) and heparan-sulphated proteoglycans (HSPG) in E9–E10 wild-type
nd erbB4 2/2 embryos. (A–D) At all ages examined CSPG immunoreactivity (A–C) delineates the basal lamina of the neurepithelium,
boundaries between rhombomeres, and areas of the cranial mesenchyme. Between E9 (A) and E10 (C) CSPG immunoreactivity becomes
reduced within the forming cranial ganglia (gV and gVII/VIII) and concentrated in the area adjacent to r3 (within the area bounded by
arrowheads in C and the corresponding area shown counterstained with DAPI nuclear stain in D). CSPG immunoreactivity in the E9 erbB4
2/2 hindbrain (B) does not differ from that in wild-type embryos (compare A and B). (E, F) At E10, HSPG immunoreactivity was similar
to that of CSPG, but was comparatively sparse in the cranial mesenchyme. No differences in HSPG immunoreactivity were detected
between wild-type (E) and erbB4 2/2 (F) embryos. OV, otic vesicle; gV, trigeminal ganglion; gVII/VIII, facial/acoustic ganglia. Bars, 50 mm.
Copyright © 1999 by Academic Press. All rights of reproduction in any form reserved.
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(D–G) erbB4 mRNA has become highly concentrated at the rhom-
bomere boundaries in r3 and r5. In transverse sections through r1
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Copyright © 1999 by Academic Press. All rightgrowth-inhibitory activity from wild-type hindbrains and
bind it to patterned substrates of CS-C or CS-A in in vitro
stripe assays have not produced any conclusive effect. No
doubt very many CSPG-binding molecules are present in
the tissue extracts, only a small number of which may be
inhibitory for axon growth. Therefore, although suggestive,
our data do not yet provide a direct link between the erbB4
phenotype and the chemical pretreatment phenotype, and it
is possible that these could be mechanistically unrelated.
The ability of CSPG-binding molecules to affect the pattern
of neurite growth has previously been demonstrated in the
developing mouse cerebral cortex (Emerling and Lander,
1996) and retina (Brittis and Silver, 1994). Throughout the
hindbrain we found that C6SPG immunoreactivity colo-
calised with CSPG in mesenchyme and basement mem-
branes at all ages studied (E8–E10), and no differences were
detected in the distribution of C6SPG or CSPG between
wild-type and erbB4 2/2 embryos. This also suggests that
ulphated proteoglycans might not be directly responsible
or the inhibition of axon growth by r3 mesenchyme.
owever, some studies have shown that different CSPGs
an either inhibit (Fernaud-Espinosa et al., 1998) or promote
Faissner et al., 1994) neurite growth, and it remains pos-
ible that distinct forms of CSPGs may be regionally
istributed within the cranial mesenchyme. In contrast to
SPGs, HSPGs are generally associated with axon growth-
ermissive areas of vertebrate embryos (Walz et al., 1997;
reloar et al., 1996). In agreement with this scheme, we
etected relatively little HSPG within cranial mesenchyme
nd enzymatic digestion of HSPG in cryosections or wash-
ng with heparin did not markedly disrupt the inhibitory
ctivity. The lack of a significant effect in our experiments
ith heparin washes is perplexing, given that heparin
enerally destabilises most protein–GAG interactions.
owever, our data show that heparin washes do have a
artial effect, increasing the proportion of neurites that
row into r3 mesenchyme by 12.5% above control levels
Fig. 3), although this increase was not significant (P 5
.09). Furthermore, there is evidence that at least some
rotein–CSPG interactions can be disrupted by soluble CS,
ut are barely affected by soluble heparin (Blase et al., 1996).
t therefore seems that the inhibitory activity we describe is
redominantly bound to C6S.
Other potential candidates for the r3 mesenchyme
rowth-inhibitory activity include the ephrin and Eph re-
eptor family of guidance molecules, which have been
mplicated in patterning neural crest cell migration (Krull
t al., 1997) and motor axon outgrowth in the developing
pinal cord (Flanagan and Vanderhaeghen, 1998; Wang and
(E), r3 (F), and r5 (G), it can be seen that the expression of erbB4 has
shifted to the pial surface of the neuroepithelium (arrows). StrongFIG. 6. ErbB4 mRNA becomes expressed in cells abutting the
mesenchyme. At E9 (A–C) erbB4 is expressed in neuroepithelial
cells extending from r1 into the forebrain and also within r3 and r5,
where it is slightly more concentrated towards the rhombomere
boundaries. Transverse sections through r3 (B) and r5 (C) demon-
strate that erbB4 is expressed in the ventricular zone and through-
out the thickness of the dorsal neuroepithelium (arrows). By E10expression is also seen in the roof plate. NE, neuroepithelium;
MES, mesenchyme. Bars, 50 mm.
s of reproduction in any form reserved.
96 Golding et al.Anderson, 1997). The failure of Pi-PLC to remove the r3
mesenchyme activity in our experiments suggests that the
GPI-linked forms of ephrins (A-type) are probably not in-
volved, although further studies on the possible involve-
ment of transmembrane ephrins (B-type) are in progress.
In conclusion, we show that the embryonic cranial mes-
enchyme is far from simply being a homogeneous “support
matrix” for growing axons, but instead is segmented mo-
lecularly into axon growth-permissive and growth-
inhibitory zones, possibly under the influence of erbB4-
mediated signals. Future work will now be directed at
revealing the identity and mechanism of action of this
growth inhibitor.
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